BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19734979)

  • 1. Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis.
    Jeong KH; Lew BL; Sim WY
    Acta Derm Venereol; 2009; 89(5):509-12. PubMed ID: 19734979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukaemia cutis in chronic CD8+ T lymphocytic leukaemia.
    Kishimoto H; Mamada A; Katayama I; Nishioka K
    Dermatology; 1996; 192(2):134-5. PubMed ID: 8829495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leonine facies: A unique presentation of T-prolymphocytic leukemia.
    Hasan F; Parashar Y; Rao RN; Kashyap R
    Indian J Pathol Microbiol; 2021; 64(4):817-819. PubMed ID: 34673613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythematous eruption with marked conjunctival injection--quiz case. Diagnosis: leukemia cutis with conjunctival involvement in the setting of T-cell prolymphocytic leukemia (T-PLL).
    Kaminska EC; Yu Z; Kress J; Petronic-Rosic V; Soltani K
    Arch Dermatol; 2012 Oct; 148(10):1199. PubMed ID: 23069962
    [No Abstract]   [Full Text] [Related]  

  • 5. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papuloerythroderma-like cutaneous involvement of a CD62L
    Nakagawa Y; Hamada T; Matsuda M; Kanno T; Kondo T; Takahashi T; Watanabe T; Okada K; Kawakami T; Miyake T; Morizane S; Iwatsuki K
    J Dermatol; 2019 Jan; 46(1):65-69. PubMed ID: 30450688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
    Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
    Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate].
    Maeda A; Iwai K; Ishibashi T
    Rinsho Ketsueki; 2009 Aug; 50(8):658-62. PubMed ID: 19915381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infiltration of the thyroid gland by T-cell prolymphocytic leukemia.
    Fujiwara K; Fukuhara T; Kitano H; Okazaki T
    Thyroid; 2014 Aug; 24(8):1314-8. PubMed ID: 24762052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
    Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
    Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
    Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
    Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of T-cell prolymphocytic leukemia].
    Ozaki S; Kawachi Y; Igaki T; Ogasawara N; Uchida T; Mori M; Setsu S; Machii T
    Rinsho Ketsueki; 1992 Jun; 33(6):817-22. PubMed ID: 1433923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell prolymphocytic leukemia (T-PLL) with overlapping cytomorphological features with T-CLL and T-ALL: a case initially diagnosed by fine-needle aspiration cytology and immunocytochemistry.
    Das DK; Pathan SK; Joneja M; Al-Musawi FA; John B; Mirza KR
    Diagn Cytopathol; 2013 Apr; 41(4):360-5. PubMed ID: 21987484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and Immunophenotypic Properties of Small Cell Variant of T-cell Prolymphocytic Leukemia].
    Yu YP; Wang LP; Song P; Mei JG; An ZM; Zhou XG; Li F; Tang YM; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):8-15. PubMed ID: 28245368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
    Murase K; Matsunaga T; Sato T; Kuribayashi K; Kogawa K; Kawano Y; Okamoto T; Takayama T; Watanabe H; Niitsu Y; Hirayama Y
    Int J Clin Oncol; 2003 Dec; 8(6):391-4. PubMed ID: 14663643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell prolymphocytic leukemia: A rare disease in an elderly female.
    Madaris L
    J Am Acad Nurse Pract; 2010 Dec; 22(12):648-53. PubMed ID: 21129072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukaemic cutaneous T-cell lymphoma-manifesting papuloerythroderma with CD3(-) CD4(+) phenotype.
    Shimauchi T; Sugita K; Nakamura M; Tokura Y
    Acta Derm Venereol; 2010; 90(1):68-72. PubMed ID: 20107729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous infiltration in T-cell prolymphocytic leukaemia.
    Mallett RB; Matutes E; Catovsky D; Maclennan K; Mortimer PS; Holden CA
    Br J Dermatol; 1995 Feb; 132(2):263-6. PubMed ID: 7888364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.